戻る
Cytokinetics Shares Advance Following Positive Aficamten Clinical Data Presentation
戻る
株式ニュース
テーマ
Cytokinetics Shares Advance Following Positive Aficamten Clinical Data Presentation
Cytokinetics Shares Advance Following Positive Aficamten Clinical Data Presentation
Edgen Stock
·
Sep 29 2025, 12:41
共有先
共有先
リンクをコピー
ソース：
[1] Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
[2] Cytokinetics (CYTK) Reveals Promising Aficamten Data at Heart Fa - GuruFocus
[3] Cytokinetics stock maintains Buy rating at Stifel on promising aficamten data - Investing.com
Edgen Stock·Sep 29 2025, 12:41Edgen Stock·Sep 29 2025, 12:41
Edgen Stock·Sep 29 2025, 12:41